Analyst Ratings for Karuna Therapeutics Inc. (KRTX) [Neutrals]
KRTX Rating Summary
KRTX Price Target Summary
- Highest: $200.00 (Goldman Sachs)
- Lowest: $160.00 (RBC Capital)
- Average: $181.31
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$181.31 (+29.2%)
* Over Last 12-Mos
Rating Score: 9.4 / 10
Percentile Rank: 89%
Rating Score: 9.4 / 10

Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
11/19/2020 | Maxim Group | N/A | New Coverage | Hold (N/A) |
98.00 (N/A) |
98.00 (140.36) |
43.22% | Details |
KRTX Ratings News
- JPMorgan Assumes Karuna Therapeutics Inc. (KRTX) at Overweight
- SVB Leerink Starts Karuna Therapeutics Inc. (KRTX) at Outperform
- "Near Term Focus Remains on Upcoming Schizophrenia Data; Risk/Reward Remains Compelling" - Mizuho Securities Reiterates Karuna Therapeutics (KRTX) at Buy with $15 Price Target
- See More